Table 1. Molecular characteristics and antimicrobial susceptibility profile of 34 methicillin-resistant Staphylococcus aureus SCCmec type II isolated in 2015-2016.

Isolate	CCa	STa	PVLb	tst-1b	Antibiotypec	Yeard	Sourcee	Vancomycin µg/mLg
110	7	306	-	-	II	2015	T	1.5
138	5	835	+	-	II	2015	T	2.0
160	7	306	+	-	II	2015	T	1.5
165	5	63	+	-	II	2015	T	1.5
175	80	1502	-	-	II	2015	T	2.0
176	5	835	+	-	II	2015	T	2.0
177	5	63	-	-	II	2015	T	1.5
185	5	63	-	-	II	2015	T	1.5
193	5	63	-	-	II	2015	B	2.0
209	5	5	-	-	II	2015	T	1.5
211	5	835	+	-	I	2015	B	1.5
215	5	63	-	-	II	2015	B	2.0
219	5	63	-	-	II	2015	T	1.5
265	7	306	-	-	II	2015	T	2.0
332	5	835	+	-	II	2015	T	2.0
352	5	6	-	-	II	2015	T	1.5
353	5	27	-	-	II	2015	T	1.5
356	5	9	-	-	II	2015	T	2.0
369	5	27	-	-	II	2015	T	1.5
374	5	9	+	-	II	2015	B	1.5
411	5	6	-	-	II	2015	T	2.0
413	5	99	-	-	II	2015	T	1.5
415	5	5	-	-	II	2015	B	1.5
419	5	63	-	-	II	2015	T	1.5
437	5	5	-	-	II	2015	T	2.0
453	5	1307	-	-	II	2016	T	2.0
465	1290	53	-	-	III	2016	T	1.0
483	445	445	-	-	II	2016	T	2.0
484	1290	53	-	-	II	2016	B	2.0
492	445	445	-	-	II	2016	T	2.0
577	445	445	-	-	II	2016	T	1.5
578	445	445	-	-	II	2016	T	1.5
631	5	99	-	-	II	2016	B	2.0
657	445	445	-	-	II	2016	T	1.5

^aCC: Clonal Complex and ST: Sequence Typing were determined as described by Lilliebridge et al. ¹⁴ ; ^bPVL: Panton Valentine Leukocidin encoding gene and tst-1: Toxic Shock Syndrome Toxin encoding gene were detected as described in Oliveira et al. ¹⁶ ; ^cAntimicrobial resistance profile was determined by disk-diffusion assay according to the CLSI guidelines ⁸ - I: OXA; II: OXA, ERI, CLI, CIP; III: OXA, ERI, CLI, CIP, GN; OXA: Oxacillin, CLI: Clindamycin, ERI: Erithromycin, CIP: Ciprofloxacin; GN: Gentamicin; ^dYear of isolation; ^eSource of isolation, T: Tracheal secretion, B: Blood; ^fMIC vancomycin determined by E-test; - Absence; + Presence.